Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-EN
Language French English
Date Updated 2019-07-29 2019-07-29
Drug Identification Number 02268140 02268140
Brand name BRAVELLE BRAVELLE
Common or Proper name UROFOLLITROPIN FOR INJECTION, PURIFIED UROFOLLITROPIN FOR INJECTION, PURIFIED
Company Name FERRING INC FERRING INC
Ingredients
Strength(s)
Dosage form(s)
Route of administration
Packaging size 75 IU 75 IU
ATC code
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-07-18 2019-07-18
Remaining supply date 2019-07-18 2019-07-18
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments BRAVELLE is discontinued. Alternate products are available by Ferring such as REKOVELLE (follitropin delta for injection, 33.3 mcg/mL rFSH). Please contact your healthcare professional. BRAVELLE is discontinued. Alternate products are available by Ferring such as REKOVELLE (follitropin delta for injection, 33.3 mcg/mL rFSH). Please contact your healthcare professional.
Health Canada comments